International Accounting Standard IAS 36, Impairment of Assets, is the first
accounting standard that deals comprehensively with the impact of a decline
in value in assets1. IAS 36 became operative for annual
financial statements covering periods beginning on or after 1 July 19992.
Prior to the publication of IAS 36, standards such as IAS 16, Property, Plant
and Equipment, IAS 28, Accounting for Investments in Associates, and IAS 31,
Financial Reporting of Interests in Joint Ventures, included principles for
recognising impairment losses but no detailed guidance was given on how these
losses should be measured.
Financial statements exhibit reliability when amounts are stated in a prudent
manner3. The objective of IAS 36 is to prescribe the
procedures applied by an enterprise to ensure that each asset is not overstated
beyond the amount expected to be recovered through use or sale of the asset.
Impairment is assessed as at each balance sheet date on the basis of the best
set of information available to the enterprise and, subject to the application
of materiality, the accounting standard will apply even if management consider
that any impairment loss existing as at balance sheet date is likely to reverse
subsequently.
Coverage of the Standard
IAS 36 applies in general to all tangible and intangible non-financial assets,
including:
- Property, plant and equipment, irrespective of whether carried at
cost or revalued amount under IAS 16;
- Goodwill arising on an acquisition, accounted for under IAS 22;
- Investments in Subsidiaries, accounted for under IAS 27;
- Investments in Associates, accounted for under IAS 28;
- Interests in Joint Ventures, accounted for under IAS 31;
- Intangible assets, accounted for under IAS 38; and
- Investment property measured at cost, under IAS 40.
IAS 36 does not apply to the following assets covered under other accounting
standards4:
- Inventories (IAS 2, Inventories, measured at the lower of cost and net
realisable value);
- Assets arising from construction contracts (IAS 11 requires determination
of recoverable amount albeit on an undiscounted basis);
- Deferred income tax assets (IAS 12 applies);
- Assets arising from employee benefits (IAS 19 specifies that an upper limit
of such assets be determined on a discounted basis broadly compatible with
IAS 36);
- Financial assets included in the scope of IAS 32;
- Investment property measured at fair value (IAS 40 applies); and
- Biological assets measured at fair value (once IAS 41 becomes effective).
The main issues addressed by IAS 36 are:
- What is impairment?
- When is an asset assessed for impairment?
- What is the basis for assessing asset impairment (individual assets or
groups of assets)?
- How is an impairment loss measured and accounted for in the financial statements?
- In a subsequent period how is the reversal of an impairment loss measured
and accounted for in the financial statements?
- What is required to be disclosed in the financial statements about asset
impairment?
- What transitional provisions apply on initial application of the accounting
standard?
What is impairment?
An asset is described as impaired and an impairment loss is recognised
to the extent that the assets carrying amount exceeds its recoverable
amount5.
Carrying amount (CA) is the amount at which an asset is recognised in
the balance sheet after deducting any accumulated depreciation (amortisation)
and accumulated impairment losses thereon.
Recoverable amount (RA) is the higher of an assets net selling
price and its value in use.
Net selling price (NSP) is the amount obtainable from the sale of an
asset in an arms length transaction between knowledgeable, willing parties,
less the costs of disposal.
Value in use (VIU) is the present value of estimated future cash flows
expected to arise from the continuing use of an asset and from its disposal
at the end of its useful life.
Three illustrations of the definition are shown in Figure 1.
Figure 1
| (1) Compare: |
(2) Compare: |
(3) |
| Net selling price ($) |
Value in use ($) |
Recoverable amount ($) |
Carrying amount ($) |
Impairment loss, impact on carrying amount |
| 950 |
1,040 |
1,040 |
1,000 |
No impairment |
| 950 |
960 |
960 |
1,000 |
$40, asset written down to $960 |
| 940 |
920 |
940 |
1,000 |
$60, asset written down to $940 |
|
Recognition initial assessment as to whether an asset may be impaired
An assessment must be made at each balance sheet date as to whether there is
any indication that an asset is impaired6. In many cases,
this acts as the trigger point for applying the IAS. In the case of goodwill
or other intangible asset with a useful life exceeding twenty years or an intangible
asset that is not yet available for use, however, recoverable amount is determined
under IAS 36 regardless of whether or not there exists an indicator of impairment7.
Information sourced both from within and external to the enterprise is taken
into account in assessing whether an asset might be impaired. IAS 36 identifies
the following8:
External sources of information
- Significant decline in market value.
- Adverse effect of change in law, technology, relevant market place(s) or
in the economy.
- Increase in market interest rates or other market rates of return on investments.
- The reporting enterprises market capitalisation is below the carrying
amount of its net assets.
Internal sources of information
- Evidence is available of obsolescence or physical damage of an asset;
- The asset is part of a restructuring, held for disposal or will be used
differently; and
- The economic performance of an asset is, or will be, worse than expected
examples: actual results attributed to an asset are significantly less
than budget; a significant increase in maintenance costs are expected in the
next financial period.
Basis of assessment
IAS 36 requires each asset to be assessed for an indicator of impairment. When
there is an indication that an asset may be impaired, RA is estimated for each
asset6. In many cases however, it may not be possible to estimate RA of a stand-alone
asset, for example when the asset does not generate cash inflows from continuing
use that are largely independent of those from other assets9.
In such a case, RA is estimated in respect of the cash-generating unit to which
the asset belongs.
A cash-generating unit (CGU) is the smallest identifiable group of assets that
generates cash inflows from continuing use that are largely independent of the
cash inflows from other assets or groups of assets5.
The standard provides the following examples of a cash-generating unit:
A mining enterprise owns a private railway to support its mining activities.
The private railway could be sold only for scrap value and the private railway
does not generate cash inflows from continuing use that are largely independent
of the cash inflows from the other assets of the mine.
It is not possible to estimate the recoverable amount of the private railway
because the value in use of the private railway cannot be determined and it
is probably different from scrap value. Therefore, the enterprise estimates
the recoverable amount of the cash-generating unit to which the private railway
belongs, that is, the mine as a whole.
A bus company provides services under contract with a municipality that requires
minimum service on each of five separate routes. Assets devoted to each route
and the cash flows from each route can be identified separately. One of the
routes operates at a significant loss.
Because the enterprise does not have the option to curtail any one bus route,
the lowest level of identifiable cash inflows from continuing use that are largely
independent of the cash inflows from other assets or groups of assets is the
cash inflows generated by the five routes together. The cash-generating unit
for each route is the bus company as a whole.
How is an impairment loss measured and accounted for in the financial statements?
If there is an indication of impairment, the following steps are taken in relation
to the asset or CGU:
- Determine net selling price;
- Determine value in use;
- Compute recoverable amount; and
- Compare with carrying amount and allocate impairment loss.
An impairment loss for a CGU is measured in much the same way as for an individual
asset10. As discussed below, it may be necessary in the
case of a CGU to have additional consideration for the impairment of goodwill
and corporate assets.
Net selling price is the amount expected to be obtained from an arms
length sale, less directly attributed disposal costs, and essentially reflects
market price. Where a market price is not so readily available, a recent transaction
for a similar asset may assist to support an estimate of NSP.
Value in use of an asset (or CGU) is estimated by:
- Estimating the future cash inflows and outflows to be derived from continuing
use of the asset (CGU) and from its ultimate disposal; and
- Applying the appropriate discount rate to these future cash flows.
Cash flow projections are based on the most recent budgets or forecasts approved
within the enterprise. A five-year horizon applies to specific budgets or forecasts
of cash flows and, beyond that, an estimate of steady decline or growth rate
is applied until the marginal discounted net cash flow is negligible. This growth
rate generally should not exceed the long-term average growth rate reasonable
within the enterprises industry and country of operation11.
Estimates of future cash flows include:
- Inflows derived from continuing use of the asset;
- Direct operating cash outflows and overheads that can be allocated on a
reasonable and consistent basis; and
- Net cash flow expected on disposal12.
Estimates of future cash flow specifically do not include:
- The effect of a future restructuring to which the enterprise is not yet
committed or future capital expenditure, whether planned or committed13;
or
- Financing or income tax related cash flows14.
The discount rate applied should be a pre-tax rate reflective of the time value
of money and the risks specific to the asset15. Again,
judgement is required to estimate a rate that is, at least, not glaringly inappropriate.
The following reference points may assist in supporting an appropriate rate:
- Weighted average cost of capital (or required rate of return) determined
from using techniques such as the Capital Asset Pricing Model, or in applying
Economic Value Added;
- Incremental borrowing rate specific to the enterprise;
- Other market borrowing rates, for example, comparable private sector enterprise
bond yields.
The carrying amount of an individual asset is reduced to recoverable amount
as a consequence of an impairment loss16. Except to the
extent that it reverses a previous revaluation, the impairment loss is recognised
as a current period expense in the income statement. If the asset is carried
at revalued amount, for example under the allowed alternative treatment in IAS
16, Property, Plant and Equipment, an impairment loss is treated as a revaluation
decrease under that other accounting standard17.
The depreciation or amortisation charge for the asset is adjusted in future
periods to allocate the assets revised carrying amount, less its residual
value (if any), on a systematic basis over its remaining useful life18.
Allocation of impairment loss additional requirements for CGU
An impairment loss is recognised across a CGU much in the same way as for an
individual asset. It is necessary to consider how the loss is allocated amongst
the individual assets in the CGU.
The IAS requires that the loss be allocated first to goodwill attributed to
the CGU (see below) and then to the other assets pro-rata to the carrying amount
of each asset. An individual assets CA should not be reduced below the
highest of the assets NSP, VIU or zero19.
Example recognition of an impairment loss
At the end of 20X0, Cholesterol Ltd (C) acquired 100% of Butterfat Ltd (B) for
$200m. The fair value of the net identifiable assets of B was $160m and goodwill
was $40m.
B processes dairy products primarily for export to the European Union (E).
C uses straight-line depreciation and amortisation over a 20-year life for Bs
assets. No residual value is anticipated.
In 20X2, E introduces import quotas significantly restricting imports of B's
main product. As a result, and for the foreseeable future, B's production will
be cut by 45%.
The adverse change in market place and regulatory conditions is an indicator
of impairment that requires C to estimate the recoverable amount of the goodwill
and net assets of B at the end of 20X2.
The cash-generating unit for the goodwill and the identifiable assets of B
is its entire operation, since no independent cash inflows can be identified
for its individual assets.
The net selling price of Bs cash-generating unit is not determinable
therefore recoverable amount is value in use.
To determine the value in use of Bs cash-generating unit, C:
- Prepares cash flow forecasts derived from the most recent financial budgets
and forecasts for the next five years approved by management;
- Estimates subsequent cash flows based on declining growth rates; and
- Selects an appropriate discount rate, which represents a pre-tax rate that
reflects current market assessments of the time value of money and the risks
specific to the cash-generating unit.
The directors of C forecast the following net cash flows for B, inclusive of
the effect of expected inflation:
| Year |
Future cash flows ($m) |
| 20X3 |
17.2 |
| 20X4 |
18.6 |
| 20X5 |
19.7 |
| 20X6 |
20.6 |
| 20X7 |
21.2 |
Managements forecast of the growth rate after the end of the next five
years (note that this is less than the long term industry average) is +4.0%
for 20X8 and -3.0% for 20X9 and cumulatively beyond.
The management believe that a discount rate of 15% represents the pre-tax cost
that reflects current market assessments of the time value of money, the risks
specific to Bs cash-generating unit, and the effect of expected inflation.
See Figure 2 for calculations.
| Figure 2
Calculating the carrying value
| At the end of 20X2 ($m) |
Goodwill |
Indentifiable assets |
Total |
| Historical cost |
40 |
160 |
200 |
| Accumulated amortisation/depreciation |
(4) |
(16) |
(20) |
| Carrying amount |
36 |
144 |
180 |
Calculating the recoverable amount
(Value in use, over the estimated remaining useful life of the CGU)
| Year |
Long-term
growth rate |
Future net
cash flow ($m) |
PV factor @ 15%
discount rate |
Discounted future
net cash flow ($m) |
| 20X3 |
|
17.2 |
0.86957 |
15.0 |
| 20X4 |
|
18.6 |
0.75614 |
14.1 |
| 20X5 |
|
19.7 |
0.65752 |
13.0 |
| 20X6 |
|
20.6 |
0.57175 |
11.8 |
| 20X7 |
|
21.2 |
0.49718 |
10.5 |
| 20X8 |
+4% |
22.0 |
0.43233 |
9.5 |
| 20X9 |
-3% |
21.4 |
0.37594 |
8.0 |
| 20Y0 |
-6% |
20.1 |
0.32690 |
6.6 |
| 20Y1 |
-9% |
18.3 |
0.28426 |
5.2 |
| 20Y2 |
-12% |
16.1 |
0.24718 |
4.0 |
| 20Y3 |
-15% |
13.7 |
0.21494 |
2.9 |
| 20Y4 |
-18% |
11.2 |
0.18691 |
2.1 |
| 20Y5 |
-21% |
8.9 |
0.16253 |
1.4 |
| 20Y6 |
-24% |
6.7 |
0.14133 |
1.0 |
| 20Y7 |
-27% |
4.9 |
0.12289 |
0.6 |
| 20Y8 |
-30% |
3.4 |
0.10686 |
0.4 |
| Value in use |
|
|
|
106.0 |
Recognising and allocating the impairment loss
An impairment loss of $74m [180 - 106] is recognised as an expense in
the income statement for 20X2. The carrying amount of goodwill is eliminated
before reducing the carrying amount of other identifiable assets of B:
| At the end of 20X2 ($m) |
Goodwill |
Indentifiable assets |
Total |
| Historical cost |
40 |
160 |
200 |
| Accumulated amortisation/depreciation |
(4) |
(16) |
(20) |
| Carrying amount |
36 |
144 |
180 |
| Impairment loss |
(36) |
(38) |
(74) |
| Carrying amount after impairment loss |
0 |
106 |
106 |
|
Subsequent reversal of an impairment loss
The accumulated impairment loss reported in last years balance sheet may
reverse (at least in part) when there is a change in the estimates that gave
rise initially to the impairment loss.
The process by which an impairment loss reverses mirrors the process by which
the impairment loss was recognised initially. An assessment is made as to whether
there are any indicators that an impairment loss recognised previously may no
longer exist or may have decreased. The sources of information taken into consideration
act in reverse to those that might have given rise to the impairment loss initially
and would include20:
- Significant increase in market value.
- Favourable effect of change in law, technology, relevant market place(s)
or in the economy.
- Decrease in market interest rates or other market rates of return on investments.
- The enterprises market capitalisation is now above the carrying amount
of its net assets.
- Better than expected economic performance of an impaired asset.
An impairment loss reverses when, and only when, there is a change to the estimates
on which the impairment was recognised initially, for example21:
- Changed basis for RA (from NSP to VIU or vice versa);
- Significant change in the amount and/or timing of estimated future cash
flows or in the discount rate when RA was based on VIU; or
- Significant change in a component underlying NSP when RA was based on NSP.
IAS 36 specifies the following accounting treatment:
- In the case of an individual asset, an accumulated impairment loss reversal
is capped to the lower of RA and CA (net of accumulated depreciation or amortisation)
had no impairment been recognised in prior periods22.
- The impairment loss reversal is recognised as current period income in
the income statement except to the extent that it reverses a previous revaluation
decrease, in which case the impairment loss reversal would be credited to
revaluation surplus23.
- The depreciation or amortisation charge on the assets revised depreciable
amount is adjusted in future periods24.
Reversal of impairment loss additional requirements for CGU
An impairment loss previously recognised for a CGU reverses in much the same
way as for an individual asset. In addition, it is necessary to consider how
the reversal is allocated amongst the individual assets in the CGU.
The IAS requires that the reversal be allocated first to assets other than goodwill,
pro-rata to the carrying amount of each asset, capped at the lower of the individual
assets RA (if determinable) and what would have been its CA had no impairment
been recognised previously25.
Provision exists within IAS 36 for any residual impairment loss reversal to
be allocated to goodwill but the criteria is such that this is expected to be
very rare and, typically, only if the impairment of goodwill results specifically
from the initial impairment event26. See Figure 3.
| Figure 3
Example - reversal of an impairment loss
The facts are carried forward from the example above. In 20X4, following
WTO intervention, E removes the import quotas imposed two years earlier.
The favourable change in market place and regulatory conditions is an
indicator that an impairment loss may have reversed. C is required to
re-estimate the recoverable amount of Bs net assets. The recoverable
amount of B at the end of 20X4 is estimated to be $152m.
Calculating the extent to which an impairment loss can reverse
The carrying amount of Bs identifiable assets, had no impairment
loss been recognised initially, (termed "normative carrying amount"
for the purposes of this example) constitutes the maximum extent to which
an impairment loss can reverse:
| Normative at the end of 20X4 ($m) |
Indentifiable assets |
| Historical cost |
160 |
| Accumulated amortisation/depreciation |
(32) [160 x (4/20) years] |
| Normative carrying amount |
128 |
At the end of 20X2, the carrying amount of Bs identifiable assets
was $106m. Since then, two years depreciation of $12m (rounded) would
have been charged based on an estimated remaining useful life of 18 years.
At the end of 20X4, the carrying amount of Bs identifiable assets
was $94m.
Recognising and allocating the impairment loss reversal
The impairment loss recognised previously reverses to the lower of re-estimated
recoverable amount and normative carrying amount, that is $128m [lower
of 128 and 152]. Accordingly, an impairment loss reversal of $34m [128
- 94] is recognised as income in the income statement for 20X4.
| At the end of 20X4 ($m) |
Goodwill |
Indentifiable assets |
Total |
| Historical cost |
40 |
160 |
200 |
| Accumulated amortisation/depreciation |
(4) |
(28) |
(32) |
| Accumulated impairment loss |
(36) |
(4) |
(40) |
| Carrying amount after impairment loss |
0 |
128 |
128 |
The annual depreciation expense on Bs assets for 20X5 onward will
be $8m [128 / 16 years remaining].
|
Financial statement disclosure
Both IAS 36 and the accounting standard that applies specifically to the impaired
asset require financial statement disclosure about impairment. For example,
IAS 16 requires a reconciliation of the opening and closing gross carrying amount
of each class of property, plant and equipment, included in which are impairment
losses recognised and reversed during the period. The disclosure requirements
under IAS 36, summarised below, essentially fill any gaps that might exist in
other standards.
For each class of asset, in addition to the requirements of other applicable
accounting standards, when an asset (or CGU) is impaired, disclosure is required
of the:
- Amount of impairment losses recognised and reversed for the period;
- Line item(s) in the income statement where those amounts are reported;
and
- Amount of impairment losses recognised and reversed directly in equity
for the period27.
When segment information is reported under IAS 14, disclosure is required
of the amount of impairment losses recognised and reversed for each segment
reported under the primary format28.
When material to the financial statements, disclosure is required of:
- The events and circumstances that led to the recognition or reversal of
the impairment loss;
- The amount of the impairment loss recognised or reversed;
- The nature of the asset or a description of the CGU, as applicable, and
the segment affected;
- Whether the recoverable amount is based on the value in use or the net
selling price;
- The basis applied when recoverable amount is determined on net selling
price; and
- The discount rate(s) applied when recoverable amount is determined on value
in use29.
The IAS encourages, but does not require, disclosure about the key assumptions
applied in determining recoverable amounts during the period (as at balance
sheet date)30.
Transitional provision when IAS 36 is applied for the first time
IAS 36 is applied on a prospective basis only. The standard requires impairment
losses and reversals of impairment losses, recognised on the adoption of IAS
36, to be reported in the income statement for the current period unless an
asset is carried at revalued amount. An impairment loss (reversal of impairment
loss) on a revalued asset is treated as a revaluation decrease (increase)31.
References
- NB: Decline in value is a different concept to depreciation, the latter
dealing with the inter- period allocation of cost.
- IAS 36, Impairment of Assets, IASC, June 1998, para. 122.
- Reliability is one of the four principal qualitative characteristics of
a general purpose financial report. Refer to the Framework for the Preparation
and Presentation of Financial Statements, IASC, para. 24 et seq.
- IAS 36, para. 1.
- Ibid., para. 5 for definitions.
- Ibid., para. 8.
- IAS 22, para. 56, and IAS 38, para. 99.
- IAS 36, para. 9.
- Ibid., para. 65 & 66.
- Ibid., para. 15.
- Ibid., para. 27.
- Ibid., para. 32.
- Ibid., para. 37.
- Ibid., para. 43.
- Ibid., para. 48.
- Ibid., para. 58.
- Ibid., para. 59.
- Ibid., para. 62.
- Ibid., para. 88 & 89.
- Ibid., para. 95 & 96.
- Ibid., para. 99 et seq.
- Ibid., para. 102.
- Ibid., para. 104.
- Ibid., para. 106.
- Ibid., para. 107 & 108.
- Ibid., para. 109.
- Ibid., para. 113.
- Ibid., para. 116.
- Ibid., para. 117 & 118.
- Ibid., para. 119.
- Ibid., para. 120.
Simon Riley is Deputy Director (Accounting), Hong Kong Society of Accountants
|